STOCK TITAN

Philips and Gibraltar Health Authority announce 16-year strategic partnership, transforming patient imaging and cardiac care at St Bernard’s Hospital

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
partnership
Rhea-AI Summary

On March 7, 2023, Royal Philips (NYSE: PHG) announced a long-term strategic partnership with the Gibraltar Health Authority to enhance local cardiac care by establishing a new interventional cardiac suite at St Bernard’s Hospital. This initiative will eliminate the need for patients to travel to Spain for treatments like coronary angioplasty and catheterization. The suite's construction will take 9-12 months, improving patient outcomes and operational efficiency. Additionally, Philips will upgrade existing hospital equipment, including X-ray and ultrasound systems, supporting better diagnostic capabilities and expanding cardiology services.

Positive
  • Establishment of a new interventional cardiac suite expected to improve patient care in Gibraltar.
  • Reduction in patient travel for cardiac treatment, enhancing local healthcare access.
  • Upgrades to existing diagnostic equipment will improve operational efficiency and patient outcomes.
  • Long-term partnership may lead to sustainable advancements in healthcare technology.
Negative
  • Construction and installation of the new suite will take 9-12 months, delaying immediate benefits.
  • -

March 07, 2023

For the first time, patients will no longer need to travel abroad for treatment of acute cardiac diseases, as the Gibraltar Health Authority prepares to provide local coronary angiography and angioplasty services in a new interventional cardiac suite

Amsterdam, the Netherlands and Gibraltar – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the Gibraltar Health Authority, today announced they have signed a long-term strategic partnership continuing their long-standing relationship and marking ambitions to advance radiology and cardiology patient care. As part of the agreement, the building of a brand-new interventional cardiac suite (cath lab) will commence later this year. The construction and installation of this specialist equipment will take approximately 9-12 months and will be accompanied by a service agreement to ensure ongoing maintenance of the equipment.

Gibraltar’s newly improved services will bring sustainable benefits for patients at St Bernard’s Hospital, with developments expected to lead to more cardiac patients receiving local treatment, instead of traveling across the border to neighboring Spain. Expected clinical outcomes include reduced length of stays for such patients, relieving pressure on demand for hospital beds and ambulance transport services, and improvement in 30-day mortality rates.

The new interventional suite will bring St Bernard’s Hospital’s services up to full operating capacity, allowing more patients to receive a range of cardiology treatments such as coronary angioplasty, catheterization to treat artery blockages and minimally invasive replacement of heart valves. In parallel, existing Philips systems within the hospital will be upgraded with the latest technology, including the replacement of equipment in two X-ray rooms, a fluoroscopy room for real-time moving X-ray imagery and ultrasound systems. As part of the agreement, a new CT system will reduce downtime and delays in diagnostics whilst creating opportunities for St Bernard’s cardiology and radiology teams to further expand services. This could see the Gibraltar Health Authority continue to bring care closer to home for future patients, such as through the availability of coronary CT scanning.

“This new chapter in our partnership with the Gibraltar Health Authority will give both clinicians and the community of Gibraltar access to innovative technologies beyond the next decade,” said Mark Leftwich, Managing Director for Philips UK and Ireland. “For the first time, clinical staff will be able to manage acute cardiac diseases, such as heart attacks, in a purpose-built suite, whilst Philips imaging systems and informatics will enable faster scanning time and enhanced collaboration. This will help create more efficiency and capacity within the departments and improved image quality will support safer diagnosis.” 

Professor Patrick Geoghegan OBE, Director General Gibraltar Health Authority said: “We are delighted to renew and strengthen our relationship with Philips with this new partnership. The impact that this new diagnostic equipment will have on our operation and on the quality of care we will be able to provide for our community is huge. Gibraltar Health Authority continues to strive to provide the best healthcare to the people of Gibraltar.”

For further information, please contact:

Joost Maltha 
Philips Global Press Office 
Tel: +31 6 10 55 8116  
E-mail: joost.maltha@philips.com

Dominique Monaghan
Philips UK and Ireland Press Office
Tel: +44 7975 755 514
E-mail: dominique.monaghan@philips.com

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring, and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

About Gibraltar Health Authority
The GHA delivers Primary, Secondary and Mental Health Care in Gibraltar. It uses a Healthcare model closely linked to the NHS, and for this purpose some tertiary referrals are delivered in the NHS as well as in Spanish hospitals due to the proximity.

Attachments


FAQ

What is the new partnership between Royal Philips and Gibraltar Health Authority about?

The partnership focuses on creating a new interventional cardiac suite at St Bernard’s Hospital to improve local cardiac care.

How will the new cardiac suite impact patients in Gibraltar?

The new cardiac suite will allow patients to receive treatments locally, reducing the need for travel to Spain.

What types of treatments will be available at the new cardiac suite?

The suite will offer treatments such as coronary angioplasty, catheterization, and minimally invasive heart valve replacements.

When will the new interventional cardiac suite be operational?

Construction and installation of the suite are expected to take 9-12 months.

How is Royal Philips enhancing healthcare in Gibraltar?

Philips is upgrading existing hospital equipment and providing innovative technologies to improve diagnostics and treatment outcomes.

KONINKLIJKE PHILIPS N.V.

NYSE:PHG

PHG Rankings

PHG Latest News

PHG Stock Data

25.07B
931.99M
6.87%
0.28%
Medical Devices
Healthcare
Link
United States of America
Amsterdam